<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">378</article-id><article-id pub-id-type="doi">10.17816/psaic378</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Criptogenic and symptomatic temporal epilepsies in adults</article-title><trans-title-group xml:lang="ru"><trans-title>Криптогенные и симптоматические височные эпилепсии у взрослых</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8706-7317</contrib-id><name-alternatives><name xml:lang="en"><surname>Kotov</surname><given-names>Sergey V.</given-names></name><name xml:lang="ru"><surname>Котов</surname><given-names>Сергей Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Head, Department of neurology, Faculty of advanced training for doctors</p></bio><bio xml:lang="ru"><p>д.м.н., зав. каф. неврологии факультета усовершенствования врачей</p></bio><email>kotovsv@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rudenko</surname><given-names>A. M.</given-names></name><name xml:lang="ru"><surname>Руденко</surname><given-names>A. M.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kotovsv@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">M.F. Vladimirsky Moscow Regional Research and Clinical Institute</institution></aff><aff><institution xml:lang="ru">ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Moscow Regional Research Clinical Institute (MONIKI)</institution></aff><aff><institution xml:lang="ru">ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2009-06-14" publication-format="electronic"><day>14</day><month>06</month><year>2009</year></pub-date><volume>3</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>9</fpage><lpage>13</lpage><history><date date-type="received" iso-8601-date="2017-02-07"><day>07</day><month>02</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2009, Kоtov A.S., Rudenko A.M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2009, Kоtov A.S., Rudenko A.M.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="en">Kоtov A.S., Rudenko A.M.</copyright-holder><copyright-holder xml:lang="ru">Kоtov A.S., Rudenko A.M.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/378">https://annaly-nevrologii.com/pathID/article/view/378</self-uri><abstract xml:lang="en"><p> </p><p>Five hundred thirty six patients with focal epilepsy, including 136 patients with temporal epilepsy (TE) aged 17–79 years were examined. In all patients specific therapy with antiepileptic drugs was initiated or corrected. The lack of pathological EEG changes was registered in 33 patients (24.3%), regional slowness in temporal zones was found in 22 (16.2%), focal epileptoform activity of the same localization – in 75 (55.1%), and diffuse epileptiform activity – in 6 (4.4%). On MRI, no changes in the brain were found in 50 patients (36.8%), non-epileptogenic changes (hydrocephaly, retrocerebellar cycts, etc.) were diagnosed in 17 (12.5%), moderately epileptogenic changes (post-stroke and posttraumatic cycts, foci of gliosis, etc.) in 42 (30.9%), and highly epileptogenic in 14 (10.3%), including hippocampal sclerosis in 8 (5.9%). The vast majority of adult TE cases were found to manifest with combination of secondarily generalized and focal (partial) seizures, the latter being predominantly automotor (32.3%) and dialeptic (27.9%). Medication remission among the patients under study was achieved in only 28.2% of cases; this confirms the opinion that TE represents not only the most frequent form of focal epilepsy in adults, but also great challenge for cure.</p>  <p> </p> <p> </p></abstract><trans-abstract xml:lang="ru"><p>Обследовано 536 пациентов с фокальной эпилепсией, включая 136 больных височной эпилепсией (ВЭ) в возрасте от 17 до 79 лет. Всем пациентам была назначена впервые или подвергнута коррекции текущая терапия антиэпилептическими препаратами. По данным ЭЭГ отсутствие патологических изменений было констатировано у 33 пациентов (24,3%), региональное замедление в височных областях выявлялось у 22 (16,2%), фокальная эпилептиформная активность той же локализации – у 75 (55,1%), нелокализованная эпилептиформная активность – у 6 (4,4%). При проведении МРТ не было обнаружено патологических изменений головного мозга у 50 пациентов (36,8%), неэпилептогенные изменения (гидроцефалия, ретроцеребеллярные кисты и т.д.) диагностированы у 17 (12,5%), умеренно эпилептогенные (постинсультные и посттравматические кисты, очаги глиоза и т.д.) – у 42 (30,9%), высокоэпилептогенные – у 14 (10,3%), в т.ч. гиппокампальный склероз – у 8 (5,9%). Установлено, что в подавляющем большинстве случаев у взрослых с ВЭ заболевание проявляется сочетанием вторично генерализованных и фокальных (парциальных) приступов, среди последних преобладают аутомоторные – у 32,3% и диалептические – у 27,9%. Медикаментозная ремиссия среди включенных в исследование пациентов была достигнута лишь в 28,2% случаев; это подтверждает мнение о том, что ВЭ – не только самая распространенная форма фокальной эпилепсии у взрослых, но и одна из наиболее труднокурабельных.</p></trans-abstract><kwd-group xml:lang="en"><kwd>cryptogenic and symptomatic temporal epilepsy</kwd><kwd>clinics</kwd><kwd>diagnosis</kwd><kwd>treatment</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>криптогенная и симптоматическая височная эпилепсия</kwd><kwd>клиника</kwd><kwd>диагностика</kwd><kwd>лечение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Петрухин А.С. Эпилепсия: частота в популяции и факторы риска ее развития. В кн.: Петрухин А.С., Мухин К.Ю., Благосклонова Н.К., Алиханов А.А. (ред.) Эпилептология детского возраста. М: Медицина, 2000: 44–63.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Brodie M., Schachter S. Fast Facts – Epilepsy. Oxford: Health Press Limited, 2001.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Cendes F., Andermann F., Dube. aeut aFl. Early childhood prolonged febrile convulsions, atrophy, and sclerosis of mesial structures and temporal lobe epilepsy: an MRI volumetric study. Neurology 1993; 43: 1083–1087.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Cendes F., Andermann F., Gloor P. et al. Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizunrens?NAeurol. 1993; 34: 795–801.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Engel J. Jr. Diagnostic evaluation. In: Seizures and Epilepsy. Philadelphia: FA Davis, 1989: 303–339.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Falconer M.A. Genetic and related etiological factors in temporal lobe epilepsy: a review. Epilepsia 1971; 12: 13–31.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. French J.A., Williamson P.D., Thadani V.M. et al. Characteristics of medial temporal ploibleepesy I. Results of history and physical examination. Ann. Neurol. 1993; 34: 774–780.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Jacobs R., Harvey A.S., Anderson V. Executive function following focal frontal lobe lesions: impact of timing of lesion on outcome. Cortex 2007; 43: 792–805.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Von Oertzen J., Urbach H., Jungbluth S. et al. Standard magnetic resonance imaging is inadequeatfor patients with refractory focal epilepsy. J. Neurol. Neurosurg. Psychiatry 2002; 73: 643–674.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Majores M., Schoch S., Lie A. et al. Molecular neuropathology of temporal lobe epilepsy: complementary approaches in animal models and human disease tissue. Epilepsia 2007; 48 (Suppl. 2): 4–12.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Mathern G.W., Pretorius J.K., Babb T.L. Influence hofettype of initial precipitating injury and at what age it occurs on course and outcome in patients with temporal lobe seizures. J. Neurosurg. 1995; 82: 220–227.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Okada R., Moshe S.L., Albala B.J. Infantile status epilepticus and future seizure susceptibility in the rat. Dev. Brain Res. 1984; 15: 177–183.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Ray A., Kotagal P. Temporoalbel epilepsy in children: overview of clinical semiology. Epileptic Disord. 2005; 7: 299–307.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Saygi S., Spencer S.S., Scheyer R. et al. Differentiation of temporal lobe ictal behavior associated with hippocampal sclerosis and tumors of temporal lobe. Epilepsia 1994; 35: 737–742.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Semah F., Picot M. C., Adam C. et al. Is the underlying cf aeupsie o lepsy a major prognostic factor for recurrence? Neurology 1998; 51: 1256–1262.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Spooner C.G., Berkovic S.F., Mitchell L.A. et al. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 2006; 67: 2147–2153.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Sussman N.M., Jackel R.A., Kaplan L.R. et al. Bicycling movements as a manifesattion of complex partial seizures of temporal lobe origin. Epilepsia 1989; 30: 527–531.</mixed-citation></ref></ref-list></back></article>
